Filter
715
Featured
57
194
Language
Document type
368
137
108
43
33
9
8
6
1
1
1
Countries
34
33
25
20
19
18
18
16
15
13
13
12
12
10
10
10
9
8
7
7
7
7
7
7
6
6
5
5
5
4
4
4
4
4
4
4
4
4
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
279
39
37
34
27
18
7
Toolboxes
69
62
55
42
40
22
19
19
16
14
13
13
11
11
10
8
8
7
5
4
3
2
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato
...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells
...
PQDx 0179-012-00 WHO
PQDx Public Report
June/2017, version 4.0
PQDx 0183‐060‐00 WHO
PQ Public Report
October/2016, version 5.0
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
PQDx 0053-006-00 WHO
PQ Public Report
June/2016, version 2.0
PQDx 0018-010-00 WHO
PQDx PR
July/2016, version 3.0
PQDx 0198-071-00
WHO PQDx PR
April/2016, version 2.0
PQDx 0005-005-00
WHO PQDx PR
May/2016, version 3.0
Public Report
PQMC 0003-003-00 WHO PQMC PR June/2015, version 2.0
Public Report
PQMC 0001-001-04 WHO PQMC Public Report November/2016, version 8.0
WHO/UNICEF/UNFPA joint statement
Three Years After Enactment of the Drug Quality and Security Act
Infectious disease outbreaks are periods of
great uncertainty. Events unfold, resources
and capacities that are often limited
are stretched yet further, and decisions
for a public health response must be
made quickly, even though the evidence
for decision-making may be scant. In
such a
...
